FDA Approval. The U.S. Food and Drug Administration has not delivered a letter of nonapproval, nor threatened to deliver such a letter, with respect to any product manufactured, marketed, licensed or developed by Rigel, or any product which Rigel intends to manufacture, market, license or develop.
Appears in 4 contracts
Samples: Collaborative Research and License Agreement (Rigel Pharmaceuticals Inc), Collaborative Research and License Agreement (Rigel Pharmaceuticals Inc), Collaborative Research and License Agreement (Rigel Pharmaceuticals Inc)